Llew Keltner, Director at Raptor Pharmaceutical Corp (RPTP), sold 967 shares at $5.49 ($5K) on 2012-09-17, disclosed to the SEC on 2012-09-18.
Scheduled sale ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.49 | 139 | $763 | 14.4% |
| 2 | $5.49 | 828 | $5K | 85.6% |
| Total | $5.49 avg | 967 | $5K | 100% |
| Filing → |
| RPTP | BUY | 2014-06-03 | $837 | — | Filing → |
| RPTP | SELL | 2014-03-11 | $157K | — | Filing → |
| RPTP | SELL | 2014-01-09 | $133K | — | Filing → |